A comparison between anti-TH/To- and anticentromere antibody-positive systemic sclerosis patients with limited cutaneous involvement

Arthritis and Rheumatism

Volumn 48, Issue 1, 2003, Pages 203-209

  Mitri, Ghaith M ^a   Lucas, Mary ^b   Fertig, Noreen ^b   Steen, Virginia D ^c   Medsger, Thomas A ^b  

^a HealthStar Physicians   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CENTROMERE ANTIBODY; THYROID ANTIBODY;

ADULT; ANTIBODY DETECTION; ARTICLE; DISEASE DURATION; ESOPHAGUS MOTILITY; FEMALE; HUMAN; IMMUNOPRECIPITATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RADIOGRAPHY; RNA PROCESSING; SEROCONVERSION; SKIN MANIFESTATION; SKINFOLD THICKNESS; SURVIVAL; SYSTEMIC SCLEROSIS;

EID: 0037231639     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.10760     Document Type: Article

References (26)

1. Medsger TA Jr. Systemic sclerosis (scleroderma): clinical aspects. In: Koopman WJ, editor. Arthritis and allied conditions, 14th ed. Philadelphia: Lippincott, Williams & Wilkins; 2001. p. 1590-624.
2. Rodnan GP, Jablonska S, Medsger TA Jr. Classification and nomenclature of progressive systemic sclerosis. Clin Rheum Dis 1979;5:5-13.
3. Tan EM. Autoantibodies to nuclear antigens (ANA): their immunobiology and medicine. Adv Immunol 1982;33:167-240.
4. Okano Y, Medsger TA Jr. Antibody to Th ribonucleoprotein (nucleolar 7-2 RNA protein particle) in patients with systemic sclerosis (scleroderma). Arthritis Rheum 1990;33:1822-8.
5. Okano Y, Steen VD, Medsger TA Jr. Antibody reactive with RNA polymerase III in systemic sclerosis. Ann Intern Med 1993;119:1005-13.
6. Reimer G, Steen VD, Penning CA, Medsger TA Jr, Tan EM. Correlates between autoantibodies to nucleolar antigens and clinical features in patients with systemic sclerosis (scleroderma). Arthritis Rheum 1988;31:525-32.
7. Sharp GC, Irvin WS, Tan EM, Gould RG, Holman HR. Mixed connective tissue disease: an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA). Am J Med 1972;52:148-59.
8. Targoff IN, Reichlin M. Nucleolar localization of the PM-Sci antigens. Arthritis Rheum 1985;28:226-30.
9. Treadwell EL, Alspaugh MA, Wolfe JF, Sharp GC. Clinical relevance of PM-1 antibody and physiochemical characterization of PM-1 antigen. J Rheumatol 1984;11:658-62.
10. Okano Y, Steen VD, Medsger TA Jr. Autoantibody to U3 nucleolar ribonucleoprotein (fibrillarin) in patients with systemic sclerosis. Arthritis Rheum 1992;35:95-100.
11. Clements PJ, Lachenbruch PA, Seibold JR, Zee B, Steen VD, Brennan P, et al. Skin thickness score in systemic sclerosis: an assessment of interobserver variability in 3 independent studies. J Rheumatol 1993;20:1892-6.
12. Hardin JA, Rahn DR, Shen C, Lerner MR, Wolin SL, Rossa MD, et al. Antibodies from patients with connective diseases bind specific subsets of cellular RNA-protein particles. J Clin Invest 1982;70:141-7.
13. Reddy R, Tan EM, Henning D, Nogha K, Bush H. Detection of a nucleolar 7-2 ribonucleoprotein and cytoplasmic 8-2 ribonucleoprotein with autoantibodies from patients with scleroderma. J Biol Chem 1983;258:1383-6.
14. Hashimoto C, Steitz JA. Sequential association of nucleolar 7-2 RNA with two different autoantigens. J Biol Chem 1983;258:1379-82.
15. Gold HA, Craft J, Hardin JA, Bartkiewicz M, Altman S. Antibodies in human serum that precipitate ribonuclease P. Proc Natl Acad Sci U S A 1988;85:5483-7.
16. Gold HA, Topper JN, Clayton DA, Craft J. The RNA processing enzyme RNase MRP is identical to the Th RNP and related to RNase P. Science 1989;245:1377-80.
17. Jiang T, Altman S. Protein-protein interactions with subunits of human nuclear RNase P. Proc Natl Acad Sci U S A 2001;98:920-5.
18. Yamane K, Ihn H, Kubo M, Kawana M, Asano Y, Yazawa N, et al. Antibodies to Th/To ribonucleoprotein in patients with localized scleroderma. Rheumatology 2001;40:683-6.
19. Steen VD, Powell DL, Medsger TA Jr. Clinical correlations and prognosis based on serum autoantibodies in patients with systemic sclerosis. Arthritis Rheum 1988;31:196-203.
20. MacGregor A, Canavan R, Knight C, Denton C, Davar J, Coghlan J, et al. Pulmonary hypertension in systemic sclerosis: risk factors for progression and consequences for survival. Rheumatology (Oxford) 2000;40:453-9.
21. Gunduz OH, Fertig N, Lucas M, Medsger TA Jr. Systemic sclerosis with renal crisis and pulmonary hypertension. Arthritis Rheum 2001;44:1663-6.
22. Kuwana M, Kaburaki J, Okano Y, Tojo T, Homma M. Clinical and prognostic associations based on serum antinuclear antibodies in Japanese patients with systemic sclerosis. Arthritis Rheum 1994;37:75-81.
23. Higuchi M, Horiuchi T, Ishibashi N, Yoshizawa S, Niho Y, Nagasawa K. Anticentromere antibody as a risk factor for cancer in patients with systemic sclerosis. Clin Rheumatol 2000;19:123-6.
24. Masi AT, Rodnan GP, Medsger TA Jr, Altman R, D'Angelo W, Fries J, et al. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980;23:581-90.
25. Medsger TA Jr. Comments on Scleroderma Criteria Cooperative Study. In: Current topics in rheumatology: systemic sclerosis (scleroderma). Black CM, Myers AR, editors. New York: Gower Medical Publishing; 1985. p. 16-7.
26. Scussel-Lonzetti L, Joyal F, Raynauld J-P, Roussin A, Goulet J-R, Rich E, et al. Are the ACR systemic sclerosis classification criteria useful for diagnosis? [abstract] Arthritis Rheum 2000;43:S315.